Skip to main content

Table 5 Comparison of Y-BOCS, BDI-II, BAI, OBQ-44 and WHODAS-2 score change from week 0 in both groups

From: Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial

Control group

Intervention group

Measure

Phase

Mean ± SD

Mean ± SD

Partial Eta Squared

P-Value

F

Y-BOCS

Week 0

28.857 ± 7.262

31.600 ± 3.832

0.82*

< 0.001

60.97

Week 12

21.785 ± 7.223

18.866 ± 4.068

3 months Follow-up

23.857 ± 6.780

19.266 ± 3.863

Compulsion subscale

Week 0

13.785 ± 4.353

15.400 ± 2.501

0.69*

< 0.001

29.57

Week 12

10.428 ± 4.669

9.266 ± 2.086

3 months Follow-up

11.357 ± 4.307

9.600 ± 2.229

Obsession subscale

Week 0

15.071 ± 3.496

16.200 ± 2.144

0.61*

< 0.001

20.46

Week 12

11.357 ± 3.053

9.600 ± 2.557

3 months Follow-up

12.500 ± 3.228

9.666 ± 2.160

BDI-II

Week 0

19.857 ± 3.438

31.133 ± 36.627

0.02

0.47

0.54

Week 12

16.714 ± 3.625

25.200 ± 24.442

3 months Follow-up

16.928 ± 3.832

25.933 ± 23.398

BAI

Week 0

37.928 ± 15.137

39.266 ± 10.552

0.19

0.06

3.12

Week 12

28.285 ± 13.974

26.533 ± 5.998

3 months Follow-up

29.357 ± 13.859

26.466 ± 5.853

OBQ-44

Week 0

178.357 ± 30.114

184.133 ± 25.178

0.56*

< 0.001

16.78

Week 12

141.571 ± 29.016

130.266 ± 19.199

3 months Follow-up

141.428 ± 27.968

129.066 ± 19.177

WHODAS-2

Week 0

103.642 ± 28.489

111.800 ± 32.509

0.53*

< 0.001

14.64

Week 12

88.500 ± 27.317

89.866 ± 30.828

3 months Follow-up

93.428 ± 26.920

90.466 ± 30.220